NCT05255003 2025-12-17
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Ottawa Hospital Research Institute
Phase 4 Recruiting
Clinical Trials
15 trialsNCT05625932 2025-08-22
PROTINCOL
Galician Research Group on Digestive Tumors
Phase 3 Completed
NCT01130025 2025-02-24
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
LEO Pharma
Phase 3 Completed
NCT03090880 2022-11-17
PROVE
Assistance Publique - Hôpitaux de Paris
Phase 3 Terminated
NCT05178628 2022-03-29
imPaCT-PRO
Institute of Molecular Medicine and Biomedical Research
Phase 3 Unknown
NCT01455831 2021-05-17
PERIOP-01
Ottawa Hospital Research Institute
Phase 3 Completed
NCT03240120 2019-04-17
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
The University of Hong Kong
Phase 3 Unknown
NCT01817257 2018-10-29
ALICAT
Cardiff University
Phase 2 Terminated
NCT00981903 2017-07-06
Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer
University of Southern California
Phase 2 Terminated
NCT02260414 2017-05-11
METRO B
Centre Hospitalier Universitaire de Saint Etienne
Phase 2 Completed
NCT00475098 2016-09-02
TILT
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT01164046 2014-12-03
Longheva
University Medical Center Groningen
Phase 3 Terminated
NCT00967148 2014-10-22
PERI-OP
Ottawa Hospital Research Institute
Phase NA Completed
NCT00293501 2013-11-06
Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00629447 2013-01-07
Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients
Duke University
Phase NA Completed